دورية أكاديمية

The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

التفاصيل البيبلوغرافية
العنوان: The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use
المؤلفون: Hanaizi, Zahra, van Zwieten-Boot, Barbara, Calvo, Gonzalo, Lopez, Arantxa Sancho, van Dartel, Maaike, Camarero, Jorge, Abadie, Eric, Pignatti, Francesco
المصدر: In European Journal of Cancer January 2012 48(2):237-242
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09598049
DOI:10.1016/j.ejca.2011.09.018